UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 473

Sortiert nach

A 54-year-old man with hypertensive crisis and epigastric pain

Gaceta médica de México, 1999, Vol.135 (6), p.621

1999

Link zum Volltext

Verfügbarkeit prüfen

A 43-year-old woman with a paraneoplastic syndrome

Gaceta médica de México, 2000, Vol.136 (2), p.153

2000

Link zum Volltext

Verfügbarkeit prüfen

Panobinostat for the Treatment of Multiple Myeloma

Clinical cancer research, 2015-11, Vol.21 (21), p.4767-4773

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

Leukemia, 2015-10, Vol.29 (10), p.2110-2113

2015

Link zum Volltext

Verfügbarkeit prüfen

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

Leukemia, 2014-02, Vol.28 (2), p.384-390

2014

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

The New England journal of medicine, 2008-08, Vol.359 (9), p.906-917

2008

Link zum Volltext

Verfügbarkeit prüfen

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia

Leukemia, 2013-08, Vol.27 (8), p.1722-1728

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

Leukemia, 2011-05, Vol.25 (5), p.749-760

2011

Link zum Volltext

Verfügbarkeit prüfen

Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects

PloS one, 2012-04, Vol.7 (4), p.e34914-e34914

2012

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2259-2266

2010

Link zum Volltext

Verfügbarkeit prüfen

Pressure-induced radial collapse in few-wall carbon nanotubes: A combined theoretical and experimental study

Carbon (New York), 2017-12, Vol.125, p.429-436

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3696-3703

2013

Link zum Volltext

Verfügbarkeit prüfen

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-03, Vol.32 (3), p.309-322

2021

Link zum Volltext

Verfügbarkeit prüfen

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

Blood cancer journal (New York), 2018-11, Vol.8 (11), p.109-12, Article 109

2018

Link zum Volltext

Verfügbarkeit prüfen

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder

Brain research, 2020-03, Vol.1731, p.146359, Article 146359

2020

Link zum Volltext

Verfügbarkeit prüfen

Improved fuel properties of whole table olive stones via pyrolytic processing

Biomass & bioenergy, 2016-09, Vol.92, p.1-11

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 473

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(403)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Humans
(254)
Life Sciences & Biomedicine
(243)
Female
(147)
Male
(142)
Middle Aged
(112)
Hematology
(107)
Biological And Medical Sciences
(99)
Aged
(96)
Medical Sciences
(95)
Adult
(93)
Oncology
(76)
Multiple Myeloma
(59)
Hematologic And Hematopoietic Diseases
(51)
Multiple Myeloma - Drug Therapy
(48)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(47)
Prognosis
(47)
Treatment Outcome
(40)
Adolescent
(36)
Medicin Och Hälsovetenskap
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A 54-year-old man with hypertensive crisis and epigastric pain

A 43-year-old woman with a paraneoplastic syndrome

Panobinostat for the Treatment of Multiple Myeloma

PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

Pressure-induced radial collapse in few-wall carbon nanotubes: A combined theoretical and experimental study

Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder

Improved fuel properties of whole table olive stones via pyrolytic processing

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network

Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy

Suchergebnisse filtern